Autophagy, Inflammation, and Immunity: A Troika Governing Cancer and Its Treatment

Cell

Volumn 166, Issue 2, 2016, Pages 288-298

  Zhong, Zhenyu ^a   Sanchez Lopez, Elsa ^a   Karin, Michael ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR ANTIGEN;

ADAPTIVE IMMUNITY; AUTOPHAGY; CANCER IMMUNOTHERAPY; CANCER RISK; CARCINOGENESIS; CHRONIC INFLAMMATION; HUMAN; IMMUNOGENICITY; IMMUNOMODULATION; IMMUNOSTIMULATION; IMMUNOSURVEILLANCE; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; REVIEW; TUMOR IMMUNITY; ANIMAL; IMMUNOLOGY; IMMUNOTHERAPY; INFLAMMATION; NEOPLASMS; PATHOLOGY;

ANIMALS; AUTOPHAGY; HUMANS; IMMUNOTHERAPY; INFLAMMATION; NEOPLASMS;

EID: 84978197362     PISSN: 00928674     EISSN: 10974172     Source Type: Journal    
DOI: 10.1016/j.cell.2016.05.051     Document Type: Review

References (99)

1. Aichinger, M., Wu, C., Nedjic, J., Klein, L., Macroautophagy substrates are loaded onto MHC class II of medullary thymic epithelial cells for central tolerance. J. Exp. Med. 210 (2013), 287–300.
2. Antonucci, L., Fagman, J.B., Kim, J.Y., Todoric, J., Gukovsky, I., Mackey, M., Ellisman, M.H., Karin, M., Basal autophagy maintains pancreatic acinar cell homeostasis and protein synthesis and prevents ER stress. Proc. Natl. Acad. Sci. USA 112 (2015), E6166–E6174.
3. Apetoh, L., Ghiringhelli, F., Tesniere, A., Obeid, M., Ortiz, C., Criollo, A., Mignot, G., Maiuri, M.C., Ullrich, E., Saulnier, P., et al. Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat. Med. 13 (2007), 1050–1059.
4. Basu, S., Binder, R.J., Ramalingam, T., Srivastava, P.K., CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin. Immunity 14 (2001), 303–313.
5. Bezu, L., Gomes-de-Silva, L.C., Dewitte, H., Breckpot, K., Fucikova, J., Spisek, R., Galluzzi, L., Kepp, O., Kroemer, G., Combinatorial strategies for the induction of immunogenic cell death. Front. Immunol., 6, 2015, 187.
6. Bhullar, K.S., Hubbard, B.P., Lifespan and healthspan extension by resveratrol. Biochim. Biophys. Acta 1852 (2015), 1209–1218.
7. Bujak, A.L., Crane, J.D., Lally, J.S., Ford, R.J., Kang, S.J., Rebalka, I.A., Green, A.E., Kemp, B.E., Hawke, T.J., Schertzer, J.D., Steinberg, G.R., AMPK activation of muscle autophagy prevents fasting-induced hypoglycemia and myopathy during aging. Cell Metab. 21 (2015), 883–890.
8. Cadwell, K., Liu, J.Y., Brown, S.L., Miyoshi, H., Loh, J., Lennerz, J.K., Kishi, C., Kc, W., Carrero, J.A., Hunt, S., et al. A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells. Nature 456 (2008), 259–263.
9. Choi, A.M., Ryter, S.W., Levine, B., Autophagy in human health and disease. N. Engl. J. Med. 368 (2013), 1845–1846.
10. Chourasia, A.H., Tracy, K., Frankenberger, C., Boland, M.L., Sharifi, M.N., Drake, L.E., Sachleben, J.R., Asara, J.M., Locasale, J.W., Karczmar, G.S., Macleod, K.F., Mitophagy defects arising from BNip3 loss promote mammary tumor progression to metastasis. EMBO Rep. 16 (2015), 1145–1163.
11. Chung, H.Y., Cesari, M., Anton, S., Marzetti, E., Giovannini, S., Seo, A.Y., Carter, C., Yu, B.P., Leeuwenburgh, C., Molecular inflammation: underpinnings of aging and age-related diseases. Ageing Res. Rev. 8 (2009), 18–30.
12. Clemens, D.L., Wells, M.A., Schneider, K.J., Singh, S., Molecular mechanisms of alcohol associated pancreatitis. World J. Gastrointest. Pathophysiol. 5 (2014), 147–157.
13. Cuervo, A.M., Wong, E., Chaperone-mediated autophagy: roles in disease and aging. Cell Res. 24 (2014), 92–104.
14. Degenhardt, K., Mathew, R., Beaudoin, B., Bray, K., Anderson, D., Chen, G., Mukherjee, C., Shi, Y., Gélinas, C., Fan, Y., et al. Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. Cancer Cell 10 (2006), 51–64.
15. Dong, H., Strome, S.E., Salomao, D.R., Tamura, H., Hirano, F., Flies, D.B., Roche, P.C., Lu, J., Zhu, G., Tamada, K., et al. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat. Med. 8 (2002), 793–800.
16. Dostert, C., Pétrilli, V., Van Bruggen, R., Steele, C., Mossman, B.T., Tschopp, J., Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 320 (2008), 674–677.
17. Dou, Z., Xu, C., Donahue, G., Shimi, T., Pan, J.A., Zhu, J., Ivanov, A., Capell, B.C., Drake, A.M., Shah, P.P., et al. Autophagy mediates degradation of nuclear lamina. Nature 527 (2015), 105–109.
18. Eisenbarth, S.C., Colegio, O.R., O'Connor, W., Sutterwala, F.S., Flavell, R.A., Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature 453 (2008), 1122–1126.
19. Elliott, E.I., Sutterwala, F.S., Initiation and perpetuation of NLRP3 inflammasome activation and assembly. Immunol. Rev. 265 (2015), 35–52.
20. Eng, C.H., Wang, Z., Tkach, D., Toral-Barza, L., Ugwonali, S., Liu, S., Fitzgerald, S.L., George, E., Frias, E., Cochran, N., et al. Macroautophagy is dispensable for growth of KRAS mutant tumors and chloroquine efficacy. Proc. Natl. Acad. Sci. USA 113 (2016), 182–187.
21. Fathallah, I., Parroche, P., Gruffat, H., Zannetti, C., Johansson, H., Yue, J., Manet, E., Tommasino, M., Sylla, B.S., Hasan, U.A., EBV latent membrane protein 1 is a negative regulator of TLR9. J. Immunol. 185 (2010), 6439–6447.
22. Foretz, M., Guigas, B., Bertrand, L., Pollak, M., Viollet, B., Metformin: from mechanisms of action to therapies. Cell Metab. 20 (2014), 953–966.
23. Freeman, G.J., Long, A.J., Iwai, Y., Bourque, K., Chernova, T., Nishimura, H., Fitz, L.J., Malenkovich, N., Okazaki, T., Byrne, M.C., et al. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J. Exp. Med. 192 (2000), 1027–1034.
24. Ghiringhelli, F., Apetoh, L., Tesniere, A., Aymeric, L., Ma, Y., Ortiz, C., Vermaelen, K., Panaretakis, T., Mignot, G., Ullrich, E., et al. Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors. Nat. Med. 15 (2009), 1170–1178.
25. Greten, F.R., Arkan, M.C., Bollrath, J., Hsu, L.C., Goode, J., Miething, C., Göktuna, S.I., Neuenhahn, M., Fierer, J., Paxian, S., et al. NF-kappaB is a negative regulator of IL-1beta secretion as revealed by genetic and pharmacological inhibition of IKKbeta. Cell 130 (2007), 918–931.
26. Grivennikov, S.I., Greten, F.R., Karin, M., Immunity, inflammation, and cancer. Cell 140 (2010), 883–899.
27. Grivennikov, S.I., Wang, K., Mucida, D., Stewart, C.A., Schnabl, B., Jauch, D., Taniguchi, K., Yu, G.Y., Osterreicher, C.H., Hung, K.E., et al. Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth. Nature 491 (2012), 254–258.
28. Gross, O., Thomas, C.J., Guarda, G., Tschopp, J., The inflammasome: an integrated view. Immunol. Rev. 243 (2011), 136–151.
29. Hampe, J., Franke, A., Rosenstiel, P., Till, A., Teuber, M., Huse, K., Albrecht, M., Mayr, G., De La Vega, F.M., Briggs, J., et al. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat. Genet. 39 (2007), 207–211.
30. Harding, T.M., Morano, K.A., Scott, S.V., Klionsky, D.J., Isolation and characterization of yeast mutants in the cytoplasm to vacuole protein targeting pathway. J. Cell Biol. 131 (1995), 591–602.
31. Hayashi, Y., Tsujii, M., Wang, J., Kondo, J., Akasaka, T., Jin, Y., Li, W., Nakamura, T., Nishida, T., Iijima, H., et al. CagA mediates epigenetic regulation to attenuate let-7 expression in Helicobacter pylori-related carcinogenesis. Gut 62 (2013), 1536–1546.
32. Hsu, L.C., Enzler, T., Seita, J., Timmer, A.M., Lee, C.Y., Lai, T.Y., Yu, G.Y., Lai, L.C., Temkin, V., Sinzig, U., et al. IL-1β-driven neutrophilia preserves antibacterial defense in the absence of the kinase IKKβ. Nat. Immunol. 12 (2011), 144–150.
33. Hubbard-Lucey, V.M., Shono, Y., Maurer, K., West, M.L., Singer, N.V., Ziegler, C.G., Lezcano, C., Motta, A.C., Schmid, K., Levi, S.M., et al. Autophagy gene Atg16L1 prevents lethal T cell alloreactivity mediated by dendritic cells. Immunity 41 (2014), 579–591.
34. Ishida, Y., Agata, Y., Shibahara, K., Honjo, T., Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. EMBO J. 11 (1992), 3887–3895.
35. Karin, M., Clevers, H., Reparative inflammation takes charge of tissue regeneration. Nature 529 (2016), 307–315.
36. Kaufman, H.L., Kohlhapp, F.J., Zloza, A., Oncolytic viruses: a new class of immunotherapy drugs. Nat. Rev. Drug Discov. 14 (2015), 642–662.
37. Kepp, O., Senovilla, L., Vitale, I., Vacchelli, E., Adjemian, S., Agostinis, P., Apetoh, L., Aranda, F., Barnaba, V., Bloy, N., et al. Consensus guidelines for the detection of immunogenic cell death. OncoImmunology, 3, 2014, e955691.
38. Komatsu, M., Waguri, S., Chiba, T., Murata, S., Iwata, J., Tanida, I., Ueno, T., Koike, M., Uchiyama, Y., Kominami, E., Tanaka, K., Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature 441 (2006), 880–884.
39. Kroemer, G., Galluzzi, L., Kepp, O., Zitvogel, L., Immunogenic cell death in cancer therapy. Annu. Rev. Immunol. 31 (2013), 51–72.
40. Krummel, M.F., Allison, J.P., CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J. Exp. Med. 182 (1995), 459–465.
41. Krysko, D.V., Garg, A.D., Kaczmarek, A., Krysko, O., Agostinis, P., Vandenabeele, P., Immunogenic cell death and DAMPs in cancer therapy. Nat. Rev. Cancer 12 (2012), 860–875.
42. Ladoire, S., Enot, D., Senovilla, L., Ghiringhelli, F., Poirier-Colame, V., Chaba, K., Semeraro, M., Chaix, M., Penault-Llorca, F., Arnould, L., et al. The presence of LC3B puncta and HMGB1 expression in malignant cells correlate with the immune infiltrate in breast cancer. Autophagy 12 (2016), 864–875.
43. Lamkanfi, M., Dixit, V.M., Inflammasomes and their roles in health and disease. Annu. Rev. Cell Dev. Biol. 28 (2012), 137–161.
44. Lamming, D.W., Ye, L., Sabatini, D.M., Baur, J.A., Rapalogs and mTOR inhibitors as anti-aging therapeutics. J. Clin. Invest. 123 (2013), 980–989.
45. Levine, B., Eating oneself and uninvited guests: autophagy-related pathways in cellular defense. Cell 120 (2005), 159–162.
46. Li, H., Willingham, S.B., Ting, J.P., Re, F., Cutting edge: inflammasome activation by alum and alum's adjuvant effect are mediated by NLRP3. J. Immunol. 181 (2008), 17–21.
47. Li, B., Lei, Z., Lichty, B.D., Li, D., Zhang, G.M., Feng, Z.H., Wan, Y., Huang, B., Autophagy facilitates major histocompatibility complex class I expression induced by IFN-γ in B16 melanoma cells. Cancer Immunol. Immunother. 59 (2010), 313–321.
48. Li, N., Wu, X., Holzer, R.G., Lee, J.H., Todoric, J., Park, E.J., Ogata, H., Gukovskaya, A.S., Gukovsky, I., Pizzo, D.P., et al. Loss of acinar cell IKKα triggers spontaneous pancreatitis in mice. J. Clin. Invest. 123 (2013), 2231–2243.
49. Licastro, F., Candore, G., Lio, D., Porcellini, E., Colonna-Romano, G., Franceschi, C., Caruso, C., Innate immunity and inflammation in ageing: a key for understanding age-related diseases. Immun. Ageing, 2, 2005, 8.
50. Liu, B., Fang, M., Hu, Y., Huang, B., Li, N., Chang, C., Huang, R., Xu, X., Yang, Z., Chen, Z., Liu, W., Hepatitis B virus X protein inhibits autophagic degradation by impairing lysosomal maturation. Autophagy 10 (2014), 416–430.
51. Liu, K., Zhao, E., Ilyas, G., Lalazar, G., Lin, Y., Haseeb, M., Tanaka, K.E., Czaja, M.J., Impaired macrophage autophagy increases the immune response in obese mice by promoting proinflammatory macrophage polarization. Autophagy 11 (2015), 271–284.
52. Louvet, A., Mathurin, P., Alcoholic liver disease: mechanisms of injury and targeted treatment. Nat. Rev. Gastroenterol. Hepatol. 12 (2015), 231–242.
53. Ma, Y., Galluzzi, L., Zitvogel, L., Kroemer, G., Autophagy and cellular immune responses. Immunity 39 (2013), 211–227.
54. Ma, C., Kesarwala, A.H., Eggert, T., Medina-Echeverz, J., Kleiner, D.E., Jin, P., Stroncek, D.F., Terabe, M., Kapoor, V., ElGindi, M., et al. NAFLD causes selective CD4(+) T lymphocyte loss and promotes hepatocarcinogenesis. Nature 531 (2016), 253–257.
55. Maeda, S., Kamata, H., Luo, J.L., Leffert, H., Karin, M., IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis. Cell 121 (2005), 977–990.
56. Mah, L.Y., Ryan, K.M., Autophagy and cancer. Cold Spring Harb. Perspect. Biol., 4, 2012, a008821.
57. Malhi, H., Kaufman, R.J., Endoplasmic reticulum stress in liver disease. J. Hepatol. 54 (2011), 795–809.
58. Manzanillo, P.S., Ayres, J.S., Watson, R.O., Collins, A.C., Souza, G., Rae, C.S., Schneider, D.S., Nakamura, K., Shiloh, M.U., Cox, J.S., The ubiquitin ligase parkin mediates resistance to intracellular pathogens. Nature 501 (2013), 512–516.
59. Martinez-Lopez, N., Athonvarangkul, D., Singh, R., Autophagy and aging. Adv. Exp. Med. Biol. 847 (2015), 73–87.
60. Martinon, F., Mayor, A., Tschopp, J., The inflammasomes: guardians of the body. Annu. Rev. Immunol. 27 (2009), 229–265.
61. Martins, I., Michaud, M., Sukkurwala, A.Q., Adjemian, S., Ma, Y., Shen, S., Kepp, O., Menger, L., Vacchelli, E., Galluzzi, L., et al. Premortem autophagy determines the immunogenicity of chemotherapy-induced cancer cell death. Autophagy 8 (2012), 413–415.
62. Martins, I., Wang, Y., Michaud, M., Ma, Y., Sukkurwala, A.Q., Shen, S., Kepp, O., Métivier, D., Galluzzi, L., Perfettini, J.L., et al. Molecular mechanisms of ATP secretion during immunogenic cell death. Cell Death Differ. 21 (2014), 79–91.
63. Maurer, K., Torres, V.J., Cadwell, K., Autophagy is a key tolerance mechanism during Staphylococcus aureus infection. Autophagy 11 (2015), 1184–1186.
64. Michaud, M., Martins, I., Sukkurwala, A.Q., Adjemian, S., Ma, Y., Pellegatti, P., Shen, S., Kepp, O., Scoazec, M., Mignot, G., et al. Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice. Science 334 (2011), 1573–1577.
65. Mizushima, N., Komatsu, M., Autophagy: renovation of cells and tissues. Cell 147 (2011), 728–741.
66. Morselli, E., Maiuri, M.C., Markaki, M., Megalou, E., Pasparaki, A., Palikaras, K., Criollo, A., Galluzzi, L., Malik, S.A., Vitale, I., et al. Caloric restriction and resveratrol promote longevity through the Sirtuin-1-dependent induction of autophagy. Cell Death Dis., 1, 2010, e10.
67. Nakahira, K., Haspel, J.A., Rathinam, V.A., Lee, S.J., Dolinay, T., Lam, H.C., Englert, J.A., Rabinovitch, M., Cernadas, M., Kim, H.P., et al. Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat. Immunol. 12 (2011), 222–230.
68. Paludan, C., Schmid, D., Landthaler, M., Vockerodt, M., Kube, D., Tuschl, T., Münz, C., Endogenous MHC class II processing of a viral nuclear antigen after autophagy. Science 307 (2005), 593–596.
69. Pengo, N., Scolari, M., Oliva, L., Milan, E., Mainoldi, F., Raimondi, A., Fagioli, C., Merlini, A., Mariani, E., Pasqualetto, E., et al. Plasma cells require autophagy for sustainable immunoglobulin production. Nat. Immunol. 14 (2013), 298–305.
70. Perera, R.M., Stoykova, S., Nicolay, B.N., Ross, K.N., Fitamant, J., Boukhali, M., Lengrand, J., Deshpande, V., Selig, M.K., Ferrone, C.R., et al. Transcriptional control of autophagy-lysosome function drives pancreatic cancer metabolism. Nature 524 (2015), 361–365.
71. Pfirschke, C., Engblom, C., Rickelt, S., Cortez-Retamozo, V., Garris, C., Pucci, F., Yamazaki, T., Poirier-Colame, V., Newton, A., Redouane, Y., et al. Immunogenic Chemotherapy Sensitizes Tumors to Checkpoint Blockade Therapy. Immunity 44 (2016), 343–354.
72. Pietrocola, F., Pol, J., Vacchelli, E., Rao, S., Enot, D.P., Baracco, E.E., Levesque, S., Castoldi, F., Jacquelot, N., Yamazaki, T., et al. Caloric restriction mimetics enhance anticancer immunosurveillance. Cancer Cell, 2016, 10.1016/j.ccell.2016.05.016 Published online July 11, 2016.
73. Pua, H.H., Dzhagalov, I., Chuck, M., Mizushima, N., He, Y.W., A critical role for the autophagy gene Atg5 in T cell survival and proliferation. J. Exp. Med. 204 (2007), 25–31.
74. Randow, F., Youle, R.J., Self and nonself: how autophagy targets mitochondria and bacteria. Cell Host Microbe 15 (2014), 403–411.
75. Saitoh, T., Fujita, N., Jang, M.H., Uematsu, S., Yang, B.G., Satoh, T., Omori, H., Noda, T., Yamamoto, N., Komatsu, M., et al. Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production. Nature 456 (2008), 264–268.
76. Schmid, D., Pypaert, M., Münz, C., Antigen-loading compartments for major histocompatibility complex class II molecules continuously receive input from autophagosomes. Immunity 26 (2007), 79–92.
77. Schneider, J.L., Cuervo, A.M., Liver autophagy: much more than just taking out the trash. Nat. Rev. Gastroenterol. Hepatol. 11 (2014), 187–200.
78. Shalapour, S., Karin, M., Immunity, inflammation, and cancer: an eternal fight between good and evil. J. Clin. Invest. 125 (2015), 3347–3355.
79. Shalapour, S., Font-Burgada, J., Di Caro, G., Zhong, Z., Sanchez-Lopez, E., Dhar, D., Willimsky, G., Ammirante, M., Strasner, A., Hansel, D.E., et al. Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy. Nature 521 (2015), 94–98.
80. Sharma, P., Allison, J.P., Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential. Cell 161 (2015), 205–214.
81. Shibutani, S.T., Saitoh, T., Nowag, H., Münz, C., Yoshimori, T., Autophagy and autophagy-related proteins in the immune system. Nat. Immunol. 16 (2015), 1014–1024.
82. Silva, L.M., Jung, J.U., Modulation of the autophagy pathway by human tumor viruses. Semin. Cancer Biol. 23 (2013), 323–328.
83. Starley, B.Q., Calcagno, C.J., Harrison, S.A., Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection. Hepatology 51 (2010), 1820–1832.
84. Stolz, A., Ernst, A., Dikic, I., Cargo recognition and trafficking in selective autophagy. Nat. Cell Biol. 16 (2014), 495–501.
85. Szabo, G., Csak, T., Inflammasomes in liver diseases. J. Hepatol. 57 (2012), 642–654.
86. Tremblay, F., Krebs, M., Dombrowski, L., Brehm, A., Bernroider, E., Roth, E., Nowotny, P., Waldhäusl, W., Marette, A., Roden, M., Overactivation of S6 kinase 1 as a cause of human insulin resistance during increased amino acid availability. Diabetes 54 (2005), 2674–2684.
87. Tsugawa, H., Suzuki, H., Saya, H., Hatakeyama, M., Hirayama, T., Hirata, K., Nagano, O., Matsuzaki, J., Hibi, T., Reactive oxygen species-induced autophagic degradation of Helicobacter pylori CagA is specifically suppressed in cancer stem-like cells. Cell Host Microbe 12 (2012), 764–777.
88. Tsukada, M., Ohsumi, Y., Isolation and characterization of autophagy-defective mutants of Saccharomyces cerevisiae. FEBS Lett. 333 (1993), 169–174.
89. Twyman-Saint Victor, C., Rech, A.J., Maity, A., Rengan, R., Pauken, K.E., Stelekati, E., Benci, J.L., Xu, B., Dada, H., Odorizzi, P.M., et al. Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer. Nature 520 (2015), 373–377.
90. Umemura, A., He, F., Taniguchi, K., Nakagawa, H., Yamachika, S., Font-Burgada, J., Zhong, Z., Subramaniam, S., Raghunandan, S., Duran, A., et al. p62, upregulated during preneoplasia, induces hepatocellular carcinogenesis by maintaining survival of stressed HCC-initiating cells. Cancer Cell 29 (2016), 935–948.
91. White, E., The role for autophagy in cancer. J. Clin. Invest. 125 (2015), 42–46.
92. Yang, L., Li, P., Fu, S., Calay, E.S., Hotamisligil, G.S., Defective hepatic autophagy in obesity promotes ER stress and causes insulin resistance. Cell Metab. 11 (2010), 467–478.
93. You, M., Matsumoto, M., Pacold, C.M., Cho, W.K., Crabb, D.W., The role of AMP-activated protein kinase in the action of ethanol in the liver. Gastroenterology 127 (2004), 1798–1808.
94. Zhang, J., Ney, P.A., Role of BNIP3 and NIX in cell death, autophagy, and mitophagy. Cell Death Differ. 16 (2009), 939–946.
95. Zhang, L., Sung, J.J., Yu, J., Ng, S.C., Wong, S.H., Cho, C.H., Ng, S.S., Chan, F.K., Wu, W.K., Xenophagy in Helicobacter pylori- and Epstein-Barr virus-induced gastric cancer. J. Pathol. 233 (2014), 103–112.
96. Zhao, J., Liang, Q., Cheung, K.F., Kang, W., Dong, Y., Lung, R.W., Tong, J.H., To, K.F., Sung, J.J., Yu, J., Somatostatin receptor 1, a novel EBV-associated CpG hypermethylated gene, contributes to the pathogenesis of EBV-associated gastric cancer. Br. J. Cancer 108 (2013), 2557–2564.
97. Zhong, Z., Umemura, A., Sanchez-Lopez, E., Liang, S., Shalapour, S., Wong, J., He, F., Boassa, D., Perkins, G., Ali, S.R., et al. NF-κB Restricts Inflammasome Activation via Elimination of Damaged Mitochondria. Cell 164 (2016), 896–910.
98. Zhou, L., Littman, D.R., Transcriptional regulatory networks in Th17 cell differentiation. Curr. Opin. Immunol. 21 (2009), 146–152.
99. Zhou, R., Yazdi, A.S., Menu, P., Tschopp, J., A role for mitochondria in NLRP3 inflammasome activation. Nature 469 (2011), 221–225.